Navigation Links
sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011
Date:4/28/2011

titute, such as the Pierre and Marie Curie University (UPMC), INSERM, the French National Institute of Health and Medical Research, and CNRS, the French National Center for Scientific Research.
  • In April, sanofi-aventis announced that it has entered into a multi-year research collaboration agreement through the Stanford University Bio-X program that supports, organizes, and facilitates interdisciplinary, collaborative and innovative research projects in the early phases of development.

  • First-quarter 2011 financial resultsBusiness Net Income(1)In accordance with IFRS 5.36 and as Merial has ceased to be qualified as held for sale or exchange in Q1/2011, the results of Merial classified as held for sale or exchange in previously-issued financial statements have been reclassified and included in income from continuing operations for all periods presented.

    Sanofi-aventis generated first-quarter net sales of euro 7,779 million, down 1.5% on a reported basis or down 5.2% at constant exchange rates. "Other revenues" were euro 413 million, up 4.6% or 1.5% at constant exchange rates and included increase contribution of Plavix® and the impact of the shortage of Avalide®.

    Gross profit was euro 5,830 million (-4.7%). At constant exchange rates, gross profit decreased by 8.2%. The ratio of cost of sales to net sales reached 30.4%, compared to 27.6% in the first quarter of 2010. This evolution reflected the impact of generic competition (mainly Lovenox®, Ambien®CR and Taxotere® in the U.S. and Plavix® and Taxotere® in Europe) and higher raw heparin prices. In Q1 2010, the ratio benefited from a favorable impact due to sales of A/H1N1 vaccines.

    Research and development expenses declined by 6.0% at constant exchange rates (-4.0% on a reported basis) to euro 1,100 million, reflecting the benefit from reorganization put in place in the recent years. T
    '/>"/>

    SOURCE sanofi-aventis
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

    Related medicine technology :

    1. Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation
    2. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
    3. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
    4. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
    5. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
    6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
    7. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
    8. SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
    9. US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings
    10. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
    11. Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of Mr. C Causes Major Interest in the Scientific Community
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2014)... Conn. , Sept. 2, 2014  Numotion is pleased ... the Company,s Board of Directors. Mark is ... number of leadership positions across the organization and was a ... Corporate Executive Council. Mark spent many years running business units ... CEO of GE Healthcare Americas. "We are ...
    (Date:9/2/2014)... 2014 Reportlinker.com announces that a new ... Asia-Pacific Infusion Therapy Device Market ... Abstract: The Asia-Pacific ... infusion pumps, syringe infusion pumps, disposable infusion pumps, ... categories are segmented based on the type of ...
    (Date:9/2/2014)... YORK , Sept. 2, 2014  Reportlinker.com announces ... its catalogue: Chinese and Taiwanese Markets ... http://www.reportlinker.com/p02353211/Chinese-and-Taiwanese-Markets-for-Minimally-Invasive-Spinal-Devices.html The market for ... and Emerging region is growing at a fast ... most striking growth is happening in China ...
    Breaking Medicine Technology:Asia-Pacific Infusion Therapy Device Market 2Asia-Pacific Infusion Therapy Device Market 3Asia-Pacific Infusion Therapy Device Market 4Asia-Pacific Infusion Therapy Device Market 5Asia-Pacific Infusion Therapy Device Market 6Asia-Pacific Infusion Therapy Device Market 7Asia-Pacific Infusion Therapy Device Market 8Asia-Pacific Infusion Therapy Device Market 9Asia-Pacific Infusion Therapy Device Market 10Asia-Pacific Infusion Therapy Device Market 11Asia-Pacific Infusion Therapy Device Market 12Asia-Pacific Infusion Therapy Device Market 13Asia-Pacific Infusion Therapy Device Market 14Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 2Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 3Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 4Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 5Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 6Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 7Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 8Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 9
    ... the Most Widely Prescribed Drug for Parkinson,s Disease, ... According to a New Report from Decision Resources, ... the,world,s leading research and advisory firms focusing on pharmaceutical ... Parkinson,s,disease patients do not receive any drug treatment in ...
    ... Group Backs Construction of Facility, VIENNA, Va., Aug. ... that it has entered into an agreement with a,biomedical ... use of,a dedicated manufacturing facility for its cancer drug ... about $15 million. This,facility is located near Baltimore, Maryland. ...
    Cached Medicine Technology:Sixty-One Percent of Newly Diagnosed Parkinson's Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis 2Sixty-One Percent of Newly Diagnosed Parkinson's Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis 3CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug 2CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug 3CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug 4
    (Date:9/2/2014)... Recently, BambooIndustry.com, an excellent company in ... strand woven bamboo floors to celebrate the ... its appreciation to the frequent callers, BambooIndustry.com launched a ... addition to strand woven floors, BambooIndustry.com provides many kinds ... floors, click strand woven floors, click lock floors, wide ...
    (Date:9/2/2014)... EDT): In a Viewpoint published today in the ... of Boston researchers call for the implementation of taxes ... States. The researchers from the Friedman School of Nutrition ... Boston Children,s Hospital write that policies taxing nearly all ... people make meaningful dietary changes and substantially reduce health ...
    (Date:9/2/2014)... 2014 TCG, a leading government technology strategy ... one of the fastest-growing companies in America for the seventh ... was previously recognized in 2013, 2012, 2011, 2010, 2009, 2008, ... grown 86% from 2010 to 2013, ranking the company at ... in America - up 635 spots from 2013! More information ...
    (Date:9/2/2014)... 2014 The use of Xarelto (known ... growing at a rapid pace, even as Xarelto ... around the U.S., Bernstein Liebhard LLP reports. According to ... within a year of its 2011 launch, patients were ... a blood thinner that has been in use for ...
    (Date:9/2/2014)... Complications are rare among breast cancer patients who ... However, the researchers did find that a ... risk for certain complications than a single mastectomy. ... cancer patients who had a single (64 percent) ... were followed for 30 days after surgery. ...
    Breaking Medicine News(10 mins):Health News:Cheap Strand Woven Bamboo Floors For Autumn On Sale At BambooIndustry.com 2Health News:Taxes and subsidies could encourage healthier diet and lower healthcare costs 2Health News:TCG One of the Fastest-Growing Companies in America – for the Eighth Time! 2Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 2Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 3Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 4Health News:Complication Rates Low With Mastectomy, Breast Reconstruction: Study 2
    ... , ... holidays. Overindulge, that is; on eggnog, cookies, candy and holiday buffet fare ... not to do the same with our four-legged, furry companions. The advent ... a healthier lifestyle for our pets, according to the experts at ...
    ... , WASHINGTON, Dec. 22 After taking ... Harry Reid and Senators Max Baucus (D-MT), Christopher Dodd (D-CT) ... bill, the Chairperson and President of the National Puerto Rican ... CEO Rafael A. Fantauzzi: , "We are on the ...
    ... between 2000 and 2005, a trend that could seriously impact ... if it continues, according to a study led by researchers ... Berkeley. The findings are troubling, said the authors, ... of disability rates among older adults may have ended. Adding ...
    ... cellulose produced by bacteria could be used for artificial blood ... of blood clots than the synthetic materials currently used for ... the University of Gothenburg, Sweden. Produced by a bacterium ... enough to cope with blood pressure and works well with ...
    ... suffering through a head cold knows, food tastes wrong when ... conclude that the sense of taste operates normally only when ... that the taste system influences olfactory perception, however, has been ... Nature Neuroscience , Brandeis researchers report just such an ...
    ... ... free treatment e-cards to the military and their families , ... Philadelphia (PRWEB) December 22, 2009 -- ... online holiday program advancing the company,s commitment to offer scientifically-based sound therapy downloads without ...
    Cached Medicine News:Health News:Pets Resolve to 'Get Off On the Right Paw' in 2010 With a Healthy, Natural Diet and Exercise 2Health News:Pets Resolve to 'Get Off On the Right Paw' in 2010 With a Healthy, Natural Diet and Exercise 3Health News:Pets Resolve to 'Get Off On the Right Paw' in 2010 With a Healthy, Natural Diet and Exercise 4Health News:National Puerto Rican Coalition Urges Passage of Senate Health Bill 2Health News:Disability may be on the rise again after 20-year decline 2Health News:Disability may be on the rise again after 20-year decline 3Health News:Got taste? 2Health News:Prescription Audio Gives the Gift of Stress Relief This Holiday Season 2Health News:Prescription Audio Gives the Gift of Stress Relief This Holiday Season 3
    ... the PROTG® GPS™ Self-Expanding Nitinol ... delivered on a commitment to ... PROTG GPS Stents take that ... by adding tantalum markers at ...
    Colloidal Gold Conjugated, Streptavidin - 12 OD...
    Patent Pending lateral flow assay platform that contributes to increased sensitivty...
    Gold Labeling kit for antibodies, the Coat-Block-Run Conjugation Kit pH 8-11; contains 1 bottle each of 20 nm and 40 nm Naked Gold...
    Medicine Products: